Joseph A. Tyndall - 10 Jun 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/ Marc Began as attorney-in-fact for Joseph A. Tyndall
Issuer symbol
AXGN
Transactions as of
10 Jun 2025
Net transactions value
-$288,700
Form type
4
Filing time
11 Jun 2025, 16:22:36 UTC
Previous filing
23 May 2025
Next filing
20 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
TYNDALL JOSEPH A. Director C/O AXOGEN, INC. 13631 PROGRESS BLVD.,, SUITE 400, ALACHUA /s/ Marc Began as attorney-in-fact for Joseph A. Tyndall 11 Jun 2025 0001955281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $47,792 +7,586 +49% $6.30 22,931 10 Jun 2025 Direct
transaction AXGN Common Stock Options Exercise $28,160 +4,000 +17% $7.04 26,931 10 Jun 2025 Direct
transaction AXGN Common Stock Sale $288,700 -26,931 -100% $10.72 0 10 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Stock Option (right to purchase) Options Exercise $47,792 -7,586 -100% $6.30 0 10 Jun 2025 Common Stock 7,586 $6.30 Direct F2
transaction AXGN Employee Stock Option (right to purchase) Options Exercise $28,160 -4,000 -22% $7.04 14,248 10 Jun 2025 Common Stock 4,000 $7.04 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average sale price. These shares were sold on June 10, 2025 in multiple transactions at prices ranging from $10.69 to $10.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Options vested on the first anniversary of the grant date, which was September 1, 2023.
F3 Options vested on the first anniversary of the grant date, which was June 6, 2024.